-

Kaskela Law Firm Announces Investigation of Agilon Health, Inc. (AGL) and Encourages Long-Term AGL Shareholders with Investment Losses to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Investor litigation firm Kaskela Law announces that it is investigating Agilon Health, Inc. (NYSE: AGL) (“Agilon”) on behalf of the company’s long-term investors.

The investigation seeks to determine whether the members of Agilon’s board of directors violated the securities laws and/or breached their fiduciary duties in connection with the above alleged misconduct.

Share

Click here for additional information: https://kaskelalaw.com/case/agilon-health/

Recently a securities fraud complaint was filed against Agilon on behalf of certain investors who purchased shares of the company’s stock between April 15, 2021 and February 27, 2024. According to the complaint, during that time period Agilon and several of the company’s senior executive officers made a series of materially false and misleading statements to investors about Agilon’s medical costs.

As further detailed in the complaint, as the true information about the company’s higher medical costs was disclosed to the market, shares of the company’s stock significantly declined in value, harming the company’s long-term investors. Specifically, Agilon’s stock declined from a trading price of over $44.00 per share to less than $6.50 per share (prior to the company’s March 2026 1-for-25 reverse stock split), a decline of approximately 85% in value.

The investigation seeks to determine whether the members of Agilon’s board of directors violated the securities laws and/or breached their fiduciary duties in connection with the above alleged misconduct.

Current Agilon shareholders who purchased or acquired their AGL shares prior to May 1, 2023 are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional information about this investigation and their legal rights and options at (484) 229 – 0750, by email at abell@kaskelalaw.com, or online at:

https://kaskelalaw.com/case/agilon-health/

ABOUT KASKELA LAW:

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis (i.e., the firm’s clients are never responsible for any out-of-pocket costs for legal representation). Since 2020, the firm has helped to recover over $500 million for investors. For additional information about Kaskela Law LLC, including the firm’s recent notable recoveries for investors, please visit www.kaskelalaw.com.

This communication may constitute attorney advertising in certain jurisdictions.

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
(skaskela@kaskelalaw.com)
Adrienne Bell, Esq.
(abell@kaskelalaw.com)
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 - 0750
www.kaskelalaw.com

Kaskela Law LLC

NYSE:AGL

Release Versions

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
(skaskela@kaskelalaw.com)
Adrienne Bell, Esq.
(abell@kaskelalaw.com)
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229 - 0750
www.kaskelalaw.com

More News From Kaskela Law LLC

FOA STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Finance of America Companies Inc. (NYSE: FOA) and Encourages FOA Stockholders to Contact the Firm

NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)--Kaskela Law announces that it is investigating Finance of America Companies Inc. (NYSE: FOA) (“Finance of America”) on behalf of the company’s current stockholders.The investigation seeks to determine whether Finance of America and/or the company’s representatives violated the securities laws or breached their fiduciary duties in connection with recent corporate actions.Finance of America shareholders who would like to learn more about this investigation and...

DISTRIBUTION SOLUTIONS GROUP: Kaskela Law Announces Probe into Adequacy of $35.00 Per Share Buyout Price – Fair or Inadequately Low for the Company’s Shareholders?

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law is investigating the sufficiency of the Distribution Solutions Group, Inc. (NASDAQ: DSGR) (“DSG”) shareholder buyout proposal to determine whether DSG stockholders may be able to obtain a higher price for their shares. Sign up here to receive additional information: https://kaskelalaw.com/case/dsg/ On July 16, 2026, DSG reported that it had agreed to be acquired by private equity firm LKCM Headwater Investments (“LKCM Headwater”) at a price of $35.00 p...

INTEGER HOLDINGS: Kaskela Law Announces Probe into Adequacy of $127.00 Per Share Buyout Price – Fair or Inadequately Low for the Company’s Shareholders?

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law is currently investigating the adequacy of the Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”) shareholder buyout proposal to determine whether the Company’s investors may be able to obtain a higher price for their shares. Click here for additional information: https://kaskelalaw.com/case/integer-holdings/ On August 3, 2026, Integer announced that it had agreed to be acquired by funds affiliated with private equity firm KKR &...
Back to Newsroom